Gardell, L R; Reid, M L; Cavallero, C A et al. (1999) Amlodipine, a calcium channel inhibitor, and cocaine and ethanol's reinforcing effects. Pharmacol Biochem Behav 64:567-72
|
Cramer, C M; Hubbell, C L; Reid, L D (1998) A combination of isradipine and naltrexone blocks cocaine's enhancement of a cocaine place preference. Pharmacol Biochem Behav 60:847-53
|
Bilsky, E J; Montegut, M J; Nichols, M L et al. (1998) CGS 10746B, a novel dopamine release inhibitor, blocks the establishment of cocaine and MDMA conditioned place preferences. Pharmacol Biochem Behav 59:215-20
|
Cramer, C M; Gardell, L R; Boedeker, K L et al. (1998) Isradipine combined with naltrexone persistently reduces the reward-relevant effects of cocaine and alcohol. Pharmacol Biochem Behav 60:345-56
|
Gardell, L R; Whalen, C A; Chambers, M D et al. (1998) Valproate reduces intake of alcoholic beverage among rats. Behav Pharmacol 9:683-9
|
Pabello, N G; Hubbell, C L; Cavallaro, C A et al. (1998) Responding for rewarding brain stimulation: cocaine and isradipine plus naltrexone. Pharmacol Biochem Behav 61:181-92
|
Gonzales, P M; Boswell, K J; Hubbell, C L et al. (1997) Isradipine blocks cocaine's ability to facilitate pressing for intracranial stimulation. Pharmacol Biochem Behav 58:1117-22
|
Gardell, L R; Whalen, C A; Chattophadyay, S et al. (1997) Combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage. Alcohol Clin Exp Res 21:1435-9
|
Reid, L D; Pabello, N G; Cramer, C M et al. (1997) Isradipine in combination with naltrexone as a medicine for treating cocaine abuse. Life Sci 60:PL119-26
|
Gardell, L R; Reid, L D; Boedeker, K L et al. (1997) Isradipine and naltrexone in combination with isradipine interact with a period of abstinence to reduce rats' intakes of an alcoholic beverage. Alcohol Clin Exp Res 21:1592-8
|
Showing the most recent 10 out of 14 publications